Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,436,954 papers from all fields of science
Search
Sign In
Create Free Account
isoprodian
Known as:
4-pyridinecarboxylic acid hydrazide mixture with 2-propyl-4-pyridinecarbothioamide and 4,4'-sulfonylbis(benzenamine)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (4)
Dapsone
Drug Combinations
Prothionamide
isoniazid
Narrower (1)
L73A
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project.
R. Jacobson
,
P. Gatt
Leprosy Review
2008
Corpus ID: 1449906
The Malta Leprosy Eradication Project (MLEP) was proposed in 1971 by Freerksen with the aim of eradicating leprosy in Malta. The…
Expand
1992
1992
Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone? Isoprodian Study Group.
H. Franck
,
J. Grosset
,
+5 authors
R. Urbanczik
International journal of leprosy and other…
1992
Corpus ID: 2776603
In order to assess the potential additive liver toxicity of isoniazid to that of a thioamide-containing treatment, a prospective…
Expand
1989
1989
Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
S. Pritze
,
A. Alvarenga
,
O. Leguizamón
,
I. Haubitz
Chemotherapy
1989
Corpus ID: 46746423
In Paraguay, the National Leprosy/Tuberculosis Program is based on a combined chemotherapy with isoprodian and rifampicin. The…
Expand
1987
1987
Pulmonary tuberculosis treated with isoprodian and rifampicin or pyrazinamide.
H. Kleeberg
Chemotherapy
1987
Corpus ID: 5548879
Three regimens of 9 months' duration, 2 containing Isoprodian (isoniazid, prothionamide and dapsone) and either rifampicin or…
Expand
1979
1979
On the mechanism of the antimycobacterial activity of isoniazid + prothionamide + dapsone (Isoprodian).
R. Urbanczik
Chemotherapy
1979
Corpus ID: 23258466
Increased antimycobacterial activity of Isoprodian (isoniazid + prothionamide + dapsone) may be due to (i) decreased mutation…
Expand
Review
1975
Review
1975
Rifampicin and isoprodian in combination in the treatment of leprosy.
G. Depasquale
Leprosy Review
1975
Corpus ID: 36902800
Reviewing the progress over a 2 year period of 1 9 2 Maltese patients treated with rifampicin combined with Isoprodian, a much…
Expand
1975
1975
Report of combined therapy in leprosy with rifampicin and isoprodian conducted at the Bisidimo-center, Ethiopia.
R. Rohde
Leprosy Review
1975
Corpus ID: 37552446
On the basis of experimental results by the Borstel 62 patients (BL and LL cases) from the Bisidimo-Center, Ethiopia, received a…
Expand
1975
1975
Preliminary experience with rifampicin and isoprodian (L73A)--combination in lepromatous leprosy.
M. Hamzah
,
A. Kosasih
Leprosy Review
1975
Corpus ID: 40552077
Out of 1 3 patients under treatment, 1 0 patients so far have beco me b acteriologically nega tive, accompanied by clinicai…
Expand
1975
1975
Preliminary experience with combined therapy using rifampicin and isoprodian (L73A).
E. Freerksen
Leprosy Review
1975
Corpus ID: 33402040
1975
1975
Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
H. N. Krenzien
Leprosy Review
1975
Corpus ID: 1971533
Sixty-seven patients with lepromatous leprosy were given combined treatment with rifampicin and lsoprodian at Balaka Leprosy…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE